期刊文献+

脐带间充质干细胞与脐血CD34+细胞联合移植治疗心肌梗死 被引量:6

Cotransplantation of umbilical cord mesenchymal stem cells and umbilical cord blood CD34+ cells for the treatment of myocardial infarction
原文传递
导出
摘要 目的探讨脐带间充质干细胞(UC—MSCs)与脐血CD34+(UCB—CD34+)细胞联合移植对心肌梗死(MI)后心功能的影响。方法成年雌性日本大耳白兔17只,联合移植组和对照组各8只,1只取正常心脏。开胸结扎左心室支(LVB)建立心肌梗死模型,从脐带和脐血中分别分离间充质干细胞(MSCs)和CD34+细胞,于建模后4周二次开胸进行细胞联合移植,单纯磷酸盐缓冲液(PBS)移植作为对照。建模前、后4周及移植后4周行心脏超声心动检查左心室缩短分数(LVFS)变化,处死兔子留取心脏标本,行HE、Masson染色观察心肌纤维化程度,行免疫组织化学染色观察梗死周边血管形成和细胞分化情况。结果两组兔子基线数据差异无统计学意义。建模后两组LVFS差异无统计学意义[(31.63±2.20)%对(32.75±1.16)%,P〉0.05];移植后4周,对照组中LVFS较建模后下降[(32.00±0.76)%对(32.75±1.16)%,P〈0.05],联合移植组中较建模后升高140.13±2.48)%对(31.63±2.20)%,P〈0.01]。移植后4周,联合移植组的LVFS显著高于对照组[(40.13±2.48)%对(32.00±0.76)%,P〈0.01]。HE、Masson染色示梗死区大量心肌细胞坏死,代之以胶原纤维,且联合移植组胶原含量较对照组少;免疫组织化学染色示联合移植组梗死区域可见cTnI(+)及CD31(+)的细胞管状结构,对照组未见阳性细胞存在。结论UC—MSCs和CD34+细胞联合移植可改善心肌梗死后心功能,可能与梗死周边微血管和心肌细胞形成有关。 Objective To investigate the effect of cotransplantation of umbilical cord mesenchymal stem cells (UC-MSCs) and umbilical cord blood CD34+ (UCB-CD34 + ) cells on the heart function after myocardial infarction. Methods Ligating the left ventrieular branch(LVB) after median sternotomy to establish a model of myocardial infarction using 17 adult female Japanese white rabbits,dividing into cotransplantation group and PBS group(8 per group) ,and one is killed for the normal heart. Electrocardiogram (ECG) is measured before and after ligation of LVB and four weeks after ligation. Isolate MSCs from umbilical cord and CD34+ cells from human umbilical cord blood, respectively. Four weeks after the establishment of the model, cotransplantation is administered, and transplantation of PBS alone is as control. Ultrasonic cardiogram is given before and four weeks after the establishment of the model and four weeks after transplantation, and then rabbits are sacrificed. The hearts are taken and cut into slices for HE and Massong trichrome staining to evaluate the degree of myocardial fibrosis, and immunohistochemieal staining to evaluate neovascularization and transdifferentiation in the infarcted area. Results The baseline datas between two groups are not different. And Left ventricular fraction shortening (LVFS) after the establishment of the model have no significant difference between two groups [ (31.63 ± 2.20 ) % vs ( 32.75 ± 1.16) %, P 〉 0.05 ]. LVFS after transplantation decreased compared with LVFS before transplantation in control group [ 32.00 ± 0.76) % VS ( 32.75 ± 1.16 ) %, P 〈 0.05], but increased in eotransplantation group [(40.13 ± 2.48 ) % vs ( 31.63 ± 2.20 ) %, P 〈 0.011. After transplantation, LVFS of the cotransplantation group is higher than that of the control group, [ (40.13±2.48 ) % vs (32.00 ± 0.76) %, P 〈 0.011. As is shown by HE and Masson g trichrome staining, many cardiomyocytes are necrotic and replaced by collagenous fiber in the infarct area, immunohistoehemistry staining shows cell is with cTnI( + ) and tube structures with CD31 ( + ) in the infarcted area of the cotranspiantation group, but not in the control group. Conclusion Cotransplantation of UC-MSCs and UCB-CD34+ cells can anleliorate heart fimction, and the effect may cause by the neogenesis of the capillaries and cardiomyoeytes in the infarcted area.
机构地区 [
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2014年第2期82-85,89,共5页 Chinese Journal of Thoracic and Cardiovascular Surgery
关键词 心肌梗死 间质干细胞移植 脐血干细胞移植 Myocardial infarction Mesenchymal stem ceil transplantation Cord blood stem cell transplantation
  • 相关文献

参考文献29

  • 1Schneider C,Jaquet K,Geidel S. Transplantation of bone marrow-derived stem cells improves myocardial diastolic function:strain rate imaging in a model of hibernating myocardium[J].Journal of the American Society of Echocardiography,2009.1180-1189.
  • 2Dill T,Sch(a)ichinger V,Rolf A. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction:results of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy[J].American Heart Journal,2009.541-547.
  • 3Taghizadeh RR,Cetrulo K J,Cetrulo CL. Wharton's Jelly stem cells:future clinical applications[J].PLACENTA,2011,(Suppl 4):S311-S315.
  • 4Weiss ML,Anderson C,Medicetty S. Immune properties of human umbilical cord Wharton's Jelly-derived cells[J].STEM CELLS,2008.2865-2874.
  • 5Fong CY,Gauthaman K,Cheyyatraivendran S. Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo[J].Journal of Cellular Biochemistry,2012.658-668.
  • 6Schlechta B,Wiedemann D,Kittinger C. Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration[J].Circulation,2010.188-194.
  • 7Barclay GR,Tura O,Samuel K. Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization[J].Stem Cell Research & Therapy,2012.23.
  • 8Hu CH,Li ZM,Du ZM. Expanded human cord blood-derived endothelial progenitor cells salvage infracted myocardium in rats with acute myocardial infarction[J].Clinical and Experimental Pharmacology and Physiology,2010.551-556.
  • 9侯跃龙,李彤,严晓晔,张臣,高英堂,朱争艳.缺氧预处理对脐带间充质干细胞bFGF分泌的影响[J].解放军医学杂志,2010,35(3):297-300. 被引量:4
  • 10张臣,李彤,侯跃龙,严晓晔,朱争艳,高英堂,孙淑梅.脐血CD34^+细胞向内皮细胞诱导分化的体外研究[J].天津医科大学学报,2010,16(2):204-207. 被引量:1

二级参考文献33

  • 1Sakakibara Y, Tambara K, Sakaguchi G, et al. Toward surgical anglogenesis using slow-released basic fibroblast growth factor[J]. Eur J Cardiothorac Surg, 2003, 24(1): 105-111.
  • 2Yamamoto T, Suto N, Okubo T, et al. Intramyocardiat delivery of basic fibroblast growth factor impregnated gelatin hydrogel microspheres enhances collateral circulation to infarcted canine myocardium[J]. Jpn Circ J, 2001, 65(5): 439-444.
  • 3Rajanayagam M, Shou M, Thirumurti V, et al. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs[J]. J Am Coil Cardiol, 2000, 35(2) : 519-526.
  • 4Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement [J]. Faseb J, 2006, 20 (6) : 661-669.
  • 5Schmittgen TD, Livak KS. Analyzing real-time PCR data by the comparative Ct method[J]. Nat Protoc, 2008, 3(6): 1101-1108.
  • 6Troyer DL, Weiss ML Wharton's Jelly-derived cells are a primitive stromal cell population [J]. Stem Cells, 2008, 26(3): 591-599.
  • 7Liu Y, Sun L, Huan Y, et al. Effects of basic fibroblast growth factor microspheres on angioganesis in ischemic myccardium and cardiac function: analysis with dobutamine cardiovscular magnetic resonance tagging[J]. Eur J Cardiothorac Surg, 2006, 30(1): 103-107.
  • 8Hu X, Ys SP, Fraser JL, et al. Transplantation of hypoxia-preconditioned mesenehymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis[J]. Thorae Cardiovasc Surg, 2008, 135(4): 799-808.
  • 9Ardyanto TD, Osaki M, Tokuyasu N, et al. CoCl2-induced HIF- 1alpha expression correlates with proliferation and apoptosis in MKN- 1 cells: a possible role for the P13K/Akt pathway[J]. Int JmOncol, 2006, 29(3): 549-555.
  • 10Kerendi F, Kirshbom PM, HaIkos ME, et al. Cobalt chloride pretreatment attenuates myocardial apoptosis after hypothermic circulatory arrest[J]. Ann Thorac Surg, 2006, 81(6) : 2055-2062.

共引文献6

同被引文献123

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部